Form 4: Roivant Sciences CFO Richard Pulik Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Richard Pulik, CFO of Roivant Sciences, reports a transaction involving the disposal of common shares to cover tax obligations related to vested RSUs.
Summary
- On March 20, 2025, Richard Pulik, the CFO of Roivant Sciences Ltd., reported a transaction on SEC Form 4.
- The transaction involved the disposal of 1,504 common shares to satisfy tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $10.97.
- Following the transaction, Pulik beneficially owns 267,541 common shares.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction related to tax obligations. It doesn't indicate positive or negative sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This transaction is related to tax obligations, which is a common occurrence when RSUs vest.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes and does not indicate a change in the CFO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/20/2025 | Date of transaction (disposal of shares). |
| 03/24/2025 | Date of signature on the report. |
Keywords
Roivant Sciences, Richard Pulik, CFO, SEC Form 4, RSUs, Tax Withholding, Common Shares, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.